Longer Treatment May Benefit Some Breast Cancer Patients

For many postmenopausal women with early-stage breast cancer, treatment includes an aromatase inhibitor. Current guidelines recommend that women stay on an aromatase inhibitor for five years. But might staying on treatment for 10 years confer additional benefit? A recent study suggests the answer is yes, for some women.

Read my story

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s